[elfsight_social_share_buttons id=”1″] An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Wednesday to review data on the use of Pfizer Inc and partner BioNTech’s COVID-19 vaccine in adolescents aged 12 to 15. The vaccine is currently authorized for use in Americans aged 16 and above. The Advisory Committee […]
- Categories:
- FISM News